2022-2030 Ambulatory Health care Service Market Research Report - Regional Analysis, Top Players, Growth, Shares, Revenue
SKU ID :INH-20671039 | Published Date: 08-Apr-2022 | No. of pages: 120Description
TOC
1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCIDENCE OF CHRONIC DISEASES
6.1.2 ADVANCES IN TECHNOLOGY
6.1.3 DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.1.4 RISING GERIATRIC POPULATION
6.1.5 REIMBURSEMENT RULES
6.2 MARKET RESTRAINTS
6.2.1 MISSED/DELAYED DIAGNOSIS
6.2.2 INCIDENCE OF ADVERSE DRUG EVENTS
6.2.3 INEFFECTIVE COMMUNICATION
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 BY SURGERY TYPE
7.1.1 OPHTHALMOLOGY
7.1.2 ORTHOPEDICS
7.1.3 GASTROENTEROLOGY
7.1.4 PAIN MANAGEMENT
7.1.5 OTHER END USE SECTORS
7.2 BY APPLICATION
7.2.1 LACERATION TREATMENT
7.2.2 BONE FRACTURE TREATMENT
7.2.3 EMERGENCY CARE SERVICE
7.2.4 TRAUMA OR ACCIDENT TREATMENT
7.3 BY PRODUCT TYPE
7.3.1 OUTPATIENT DEPARTMENTS
7.3.2 PRIMARY CARE OFFICES
7.3.3 SURGICAL SPECIALTY OFFICES
7.3.4 EMERGENCY DEPARTMENTS
7.3.5 MEDICAL SPECIALTY OFFICES
7.4 BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 US
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 UK
7.4.2.3 GERMANY
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 INDIA
7.4.3.2 CHINA
7.4.3.3 JAPAN
7.4.3.4 AUSTRALIA
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF APAC
7.4.4 MIDDLE EAST AND AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF MIDDLE EAST AND AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.1 AMSURG
9.2 APRIA HEALTHCARE
9.3 DAVITA HEALTHCARE
9.4 LVL MEDICAL GROUP
9.5 FRESENIUS KABI
9.6 SONIC HEALTHCARE
9.7 HOSPITAL CORPORATION OF AMERICA (HCA) HOLDING
9.8 INTERGRAMED AMERICA INC.
9.9 SYMBION INC.
9.10 OTHERS
10. FUTURE OUTLOOK OF THE MARKET
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCIDENCE OF CHRONIC DISEASES
6.1.2 ADVANCES IN TECHNOLOGY
6.1.3 DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.1.4 RISING GERIATRIC POPULATION
6.1.5 REIMBURSEMENT RULES
6.2 MARKET RESTRAINTS
6.2.1 MISSED/DELAYED DIAGNOSIS
6.2.2 INCIDENCE OF ADVERSE DRUG EVENTS
6.2.3 INEFFECTIVE COMMUNICATION
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 BY SURGERY TYPE
7.1.1 OPHTHALMOLOGY
7.1.2 ORTHOPEDICS
7.1.3 GASTROENTEROLOGY
7.1.4 PAIN MANAGEMENT
7.1.5 OTHER END USE SECTORS
7.2 BY APPLICATION
7.2.1 LACERATION TREATMENT
7.2.2 BONE FRACTURE TREATMENT
7.2.3 EMERGENCY CARE SERVICE
7.2.4 TRAUMA OR ACCIDENT TREATMENT
7.3 BY PRODUCT TYPE
7.3.1 OUTPATIENT DEPARTMENTS
7.3.2 PRIMARY CARE OFFICES
7.3.3 SURGICAL SPECIALTY OFFICES
7.3.4 EMERGENCY DEPARTMENTS
7.3.5 MEDICAL SPECIALTY OFFICES
7.4 BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 US
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 UK
7.4.2.3 GERMANY
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 INDIA
7.4.3.2 CHINA
7.4.3.3 JAPAN
7.4.3.4 AUSTRALIA
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF APAC
7.4.4 MIDDLE EAST AND AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF MIDDLE EAST AND AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.1 AMSURG
9.2 APRIA HEALTHCARE
9.3 DAVITA HEALTHCARE
9.4 LVL MEDICAL GROUP
9.5 FRESENIUS KABI
9.6 SONIC HEALTHCARE
9.7 HOSPITAL CORPORATION OF AMERICA (HCA) HOLDING
9.8 INTERGRAMED AMERICA INC.
9.9 SYMBION INC.
9.10 OTHERS
10. FUTURE OUTLOOK OF THE MARKET
Tables & Figures
Companies
AMSURG
APRIA HEALTHCARE
DAVITA HEALTHCARE
LVL MEDICAL GROUP
FRESENIUS KABI
SONIC HEALTHCARE
HOSPITAL CORPORATION OF AMERICA (HCA) HOLDING
INTERGRAMED AMERICA INC.
SYMBION INC.
- PRICE
-
$4250$8750